The Clinical Global Impression Improvement Scale also was used at weeks 4 and 8 to evaluate whether global impairment worsened, remained steady, or improved.
What does CGI-I stand for?
CGI-I stands for Clinical Global Impression Improvement (psychological scale)
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Organizations, NGOs, schools, universities, etc.
We have 4 other meanings of CGI-I in our Acronym Attic
- Control Grid Interpolation
- Cool Globe Industries (global warming)
- Corrugated Iron
- Corruption and Governance Index
- Creative Games International, Inc (Plant City, Florida, USA)
- Creative Group, Inc. (various locations)
- Cruise Guide Indicator
- CyberGamer Invitational (gaming)
- Clinical Global Impression for Bipolar Disorder
- Clinical Global Impression of Change
- Clinical Global Impressions Severity Scale (aka Clinical Global Impressions for Severity)
- California Gang Investigators Association
- California Geographic Information Association
- Center for Geographic Information and Analysis (North Carolina)
- Centro de Gestión e Inspección Ambiental
- Colorado Government Immunity Act
- Community, Government and International Affairs (DePaul University; Chicago, IL)
- Comisión para la Gestión Integral del Agua en Bolivia (Spanish: Commission for Integrated Water Management in Bolivia; Bolivia)
- Consultative Group on International Agricultural Research
- Canadian Group Insurance Brokers
Samples in periodicals archive:
In addition, a significantly higher proportion of ropinirole participants had Clinical Global Impression improvements at week one (2.
These results were further supported by a highly significant improvement in the secondary efficacy measure, the Clinical Global Impression Improvement, or CGI-I, scale (p=0.
Secondary measures included panic attack frequency; and the Clinical Global Impression Improvement scale, which measures the physician's assessment of a patient's improvement (CGI-I < 2 were responders).
At the end of the eight week open-label treatment period, patients who had shown only a partial response to treatment (as defined by a HAM-A score of greater than or equal to 16, less than 50 percent decrease in HAM-A score, and a Clinical Global Impression Improvement score of less than 3) were then randomized to an additional eight weeks of double-blind treatment with either Lyrica (150 to 600 mg/day) or placebo while continuing treatment with the existing background SSRI or SNRI therapy.
In addition, at Weeks 8 and 10, antidepressant efficacy was evaluated using Clinical Global Impression Improvement (CGI-I) and Severity (CGI-S) scales (used by clinicians to assess improvement in a patient's MDD symptoms and the severity of their depression at various time points, respectively).
In addition to using patient-reported and clinician-administered HAM-D17 and Bech and Maier subscales, this study monitored antidepressant efficacy using Clinical Global Impression Improvement (CGI-I) and Severity (CGI-S) scales (used by clinicians to assess improvement in a patient's MDD symptoms and the severity of their depression at various time points, respectively).
The Clinical Global Impression Improvement (CGI-I) and Severity (CGI-S) scales (used by clinicians to subjectively assess improvement in a patient's symptoms and severity of depression, respectively), were also used to assess depression in this study, with assessments made at each visit.